Revolution Medicines, Inc.

RVMD· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$182.45-2.71%

2026-08-03

Financials

Valuation Metrics

Revolution Medicines, Inc.'s Market Cap is $38.79B. At end of 2025 it was $15.14B. Ranked #392 of 3,112 in US market (top 13%), #113 of 1,445 on NASDAQ (top 8%), #20 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 7%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$38.79B	US#392/3,112 Sec#20/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-1.37B	US—/3,112 Sec—/269
Total Assets	$2.25B	US#1,999/3,112 Sec#54/269
Net Assets	$1.50B	US#1,478/3,112 Sec#45/269
Value
P/B	25.86x	US#2,859/3,112 Sec#240/269
FCF Yield	-2.76%	US—/3,112 Sec—/269
Profitability
ROE	-91.45%	US#2,843/3,112 Sec#217/269
ROA	-60.86%	US#3,003/3,112 Sec#238/269
Financial Health
Debt Ratio	50.26%	US#576/3,112 Sec#139/269
Total Debt	$437M	US#1,877/3,112 Sec#60/269
FCF	$-1.07B	US#2,889/3,112 Sec#266/269
Cash	$441M	US#1,154/3,112 Sec#63/269
Current Ratio	6.80x	US#353/3,112 Sec#114/269
Performance
1Y Return	398.09%	US#28/3,112 Sec#15/269
1M Return	-3.59%	US#2,092/3,112 Sec#111/269
From 52W High	-6.22%	US#681/3,112 Sec#26/269
1Y MDD	-24.95%	US#1,034/3,112 Sec#57/269
Trading
Volume	1,442,424 shares	US#1,157/3,112 Sec#109/269
Trading Value	$264M	US#412/3,112 Sec#19/269
Per Share
EPS	$-5.95	US—/3,112 Sec—/269
BPS	$8.58	US#1,883/3,112 Sec#76/269